Furthermore, the analysis of all datasets was performed to obtain information regarding RacGAP1 expression related to race, age, sex, tumor size, disease stage, nodal metastasis, smoking habits and survival, wherever reported, thus allowing the evaluation of the relationships between RacGAP1 expression and clinicopathological features in patients with lung adenocarcinoma. The gene discussed is RACGAP1; the disease is neoplasm.